Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 28, 2023
WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer
Philip Sutera, Matthew P Deek, Kim Van der Eecken, et al.
European Urology
|
January 9, 2021
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
Matthew P Deek, Kim Van der Eecken, Ryan Phillips, et al.
The Prostate
|
October 9, 2023
TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment
Tung Hoang, Philip Sutera, Triet Nguyen, et al.
Advances in Radiation Oncology
|
May 27, 2024
Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer
Philip Sutera, Matthew P Deek, Rebecca A Deek, et al.
Clinical and Translational Radiation Oncology
|
January 24, 2023
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer
Nikhil Yegya-Raman, Timothy P Kegelman, Sang Ho Lee, et al.
BMC Cancer
|
June 15, 2019
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)
Roche Kapoor, Matthew P Deek, Riley McIntyre, et al.
The Lancet. Oncology
|
February 5, 2026
Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration
Chad Tang, Alex D Sherry, Hyunsoo Hwang, et al.
European Urology Oncology
|
April 3, 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer
Matthew P Deek, Philip Sutera, Yuezhou Jing, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 7, 2024
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer
Jarey H Wang, Matthew P Deek, Adrianna A Mendes, et al.
European Urology Oncology
|
June 11, 2024
Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer
Philip Sutera, Yang Song, Amol C Shetty, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
International Journal of Radiation Oncology, Biology, Physics
|
January 28, 2023
WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer
Philip Sutera, Matthew P Deek, Kim Van der Eecken, et al.
European Urology
|
January 9, 2021
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
Matthew P Deek, Kim Van der Eecken, Ryan Phillips, et al.
The Prostate
|
October 9, 2023
TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment
Tung Hoang, Philip Sutera, Triet Nguyen, et al.
Advances in Radiation Oncology
|
May 27, 2024
Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer
Philip Sutera, Matthew P Deek, Rebecca A Deek, et al.
Clinical and Translational Radiation Oncology
|
January 24, 2023
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer
Nikhil Yegya-Raman, Timothy P Kegelman, Sang Ho Lee, et al.
BMC Cancer
|
June 15, 2019
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)
Roche Kapoor, Matthew P Deek, Riley McIntyre, et al.
The Lancet. Oncology
|
February 5, 2026
Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration
Chad Tang, Alex D Sherry, Hyunsoo Hwang, et al.
European Urology Oncology
|
April 3, 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer
Matthew P Deek, Philip Sutera, Yuezhou Jing, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 7, 2024
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer
Jarey H Wang, Matthew P Deek, Adrianna A Mendes, et al.
European Urology Oncology
|
June 11, 2024
Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer
Philip Sutera, Yang Song, Amol C Shetty, et al.
Page
of 8